Analysts Point To Bicara Therapeutics Inc (NASDAQ: BCAX) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that N/A.

Stocks Info

As a NASDAQ listed company, BCAX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Bicara Therapeutics Inc is $789.14M. A total of 0.59 million shares were traded on the day, compared to an average of 563.00K shares.

In the most recent transaction, Meisner Lara sold 79,146 shares of BCAX for 12.90 per share on Mar 14 ’25. After the transaction, the Chief Legal Officer now owns 0 company shares. In a previous transaction on Mar 14 ’25, LARA S. MEISNER bought 79,146 shares at 13.35 per share.

Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 1,833,000 shares on Sep 16 ’24 at a per-share price of $18.00. This resulted in the Director holding 4,303,418 shares of BCAX after the transaction. In another insider transaction, Flynn James E bought 70,000 shares at $18.00 per share on Sep 17 ’24. Company shares held by the Possible Members of 10% Group now total 897,587.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BCAX has a high of $28.09 and a low of $8.91.

As of this writing, BCAX has an earnings estimate of $-0.55 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $-0.41 per share and a lower estimate of $-0.67.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCAX is Buy with a score of 4.50.

Most Popular

Related Posts